We can’t show the full text here under this license. Use the link below to read it at the source.
Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study
Costs and weight loss results of Tirzepatide use in the UK from the SURMOUNT-1 study
AI simplified
Abstract
Cost per kilogram of weight loss with was £102.86, £85.41, and £89.24 for doses of 5, 10, and 15 mg, respectively.
- Tirzepatide showed significant weight loss efficacy over 72 weeks, with greater reductions observed at higher doses.
- Average costs for achieving 5% weight loss were £1852, £1971, and £2186 for 5, 10, and 15 mg doses.
- For 10% weight loss, average costs were £2258, £2209, and £2338 across the same doses.
- The 15 mg dose was identified as the most cost-efficient option for achieving higher weight loss targets of 15% and 20%.
- Tirzepatide may lead to cost savings in healthcare by reducing obesity-related health risks.
AI simplified
Key numbers
22.5%
Weight Loss Reduction at 15 mg
Percentage weight loss achieved after 72 weeks.
£85.41
Cost per Kilogram Lost at 10 mg
Cost per kilogram of weight loss after 72 weeks.
£2186
Average Cost for 5% Weight Loss at 15 mg
Per-patient cost for achieving 5% weight loss at 72 weeks.